Brookfield Asset Management Inc. Qiagen N.V. Transaction History

Brookfield Asset Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$41.91 - $50.48 $2.84 Million - $3.43 Million	-67,882 Reduced 77.99%	19,152 $955,000
Q3 2022 Nov 14, 2022	SELL	$40.9 - $50.42 $1.95 Million - $2.4 Million	-47,614 Reduced 35.36%	87,034 $3.63 Million
Q2 2022 Nov 16, 2022	BUY	$42.98 - $49.77 $2.05 Million - $2.37 Million	47,614 Added 54.71%	134,648 $6.34 Million
Q2 2022 Aug 15, 2022	SELL	$42.98 - $49.77 $2.74 Million - $3.17 Million	-63,788 Reduced 32.15%	134,648 $6.36 Million
Q1 2022 May 16, 2022	BUY	$42.23 - $54.3 $7.32 Million - $9.42 Million	173,439 Added 693.84%	198,436 $9.72 Million
Q4 2020 Feb 16, 2021	BUY	$46.09 - $54.74 $224,227 - $266,310	4,865 Added 24.17%	24,997 $1.32 Million
Q3 2020 Nov 16, 2020	BUY	$42.51 - $52.42 $855,811 - $1.06 Million	20,132 New	20,132 $1.05 Million

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.5B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.